通过稳定ERBB3,NUF2通过调节PI3K/AKT通路来调节肝细胞癌的进展
Yiwei Liu1, Yuming Wang1, Jifei Wang1
1Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, China; Jiangsu Provincial Medical Innovation Center; Jiangsu Provincial Medical Key Laboratory, Nanjing, China.
肝细胞癌 (HCC) 中的一种蛋白质NUF2通过稳定ERBB3并激活PI3K/AKT通路来促进癌症生长. 抑制NUF2为HCC提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症相关死亡的主要原因.
- 作为NDC80基因合体综合体的一个组成部分,NUF2在HCC中受到上调,并与预后不佳有关.
- 需要阐明NUF2在HCC瘤发生中的确切作用和分子机制.
研究的目的:
- 研究NUF2在肝细胞癌中的病理生理作用.
- 探索NUF2在HCC进展中的功能背后的分子机制.
- 评估NUF2作为潜在的预后生物标志物和HCC的治疗目标.
主要方法:
- 在HCC组织中确认NUF2表达水平.
- 在体外和体内实验中评估NUF2抑制对HCC细胞的影响.
- 分析NUF2与ERBB3的相互作用及其对PI3K/AKT信号通路的影响.
主要成果:
- 在HCC组织中观察到NUF2表达显著增加,与患者不良结果相关.
- 对NUF2的遗传抑制抑制了HCC细胞的增殖,并诱导了细胞循环的破坏.
- 发现NUF2可以抑制ERBB3的泛化和降解,从而激活PI3K/AKT通路.
结论:
- 在促进肝细胞癌恶性进展方面,NUF2起着至关重要的作用.
- 通过ERBB3/PI3K/AKT轴,NUF2通过ERBB3/PI3K/AKT轴影响HCC细胞增殖和细胞周期调节.
- NUF2具有作为预后生物标志物和HCC治疗治疗点的潜力.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
